Efficacy of "Family Connections", a program for relatives of people with borderline personality disorder, in the Spanish population: study protocol for a randomized controlled trial

BMC Psychiatry
Isabel Fernández-FelipeAzucena García-Palacios

Abstract

Patients with borderline personality disorder (BPD) experience significant affect regulation difficulties that cause serious consequences in their work, emotional, and social environments. This dysfunctional pattern also produces great suffering and a heavy burden on their relatives. Fortunately, some studies show that treatment of relatives of people with BPD begins to be important in the patients' recovery and in improving family dynamics. One of the treatments that has obtained the most empirical support is Family connections (FC). This 12-session program is an adaptation of different Dialectical Behavior Therapy strategies. To test the efficacy of FC, five uncontrolled clinical trials were conducted, with pre-post treatment and follow-up assessments. The results of these studies and subsequent replications showed an improvement in family attitudes and caregiver burnout. Our research team adapted FC for delivery in the Spanish population. We intend to test the efficacy of this program versus a treatment as usual condition. Moreover, we aim to test the efficacy of this program and study its effectiveness (in terms of participants' acceptance). This paper presents the study protocol. The study is a randomized controlled trial....Continue Reading

References

Jul 1, 1997·Psychiatry·J ShachnowE Shearin
Feb 11, 2000·Family Process·P D HoffmanC R Swenson
Jun 1, 2000·The Journal of Nervous and Mental Disease·J E MezzichS Mahmud
Feb 7, 2001·The American Journal of Psychiatry·D S BenderJ G Gunderson
Jul 4, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·L DixonD Sondheimer
Sep 28, 2001·Journal of the American Podiatric Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Apr 15, 2006·Development and Psychopathology·Alan E FruzzettiPerry D Hoffman
Jan 30, 2007·Current Psychiatry Reports·Perry D Hoffman, Alan E Fruzzetti
Mar 28, 2008·The Journal of Clinical Psychiatry·Djøra I SoetemanJan J V Busschbach
Jun 11, 2008·Journal of Personality Disorders·Barbara SchneiderKlaus Georgi
Jul 11, 2009·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Mia RajalinJussi Jokinen
Mar 30, 2010·Journal of Clinical Epidemiology·David MoherUNKNOWN Consolidated Standards of Reporting Trials Group
Jul 19, 2011·General Hospital Psychiatry·Randy A SansoneMichael W Wiederman
Jan 9, 2013·Annals of Internal Medicine·An-Wen ChanDavid Moher
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Jul 16, 2014·Archives of Psychiatric Nursing·Susanne EkdahlKent-Inge Perseius
Mar 30, 2017·Borderline Personality Disorder and Emotion Dysregulation·Jessie PearceAndrew M Chanen
Mar 6, 2018·Journal of Personality Disorders·Brin F S GrenyerAnnemaree Bickerton
Jul 11, 2018·Social Psychiatry and Psychiatric Epidemiology·Ella BaruchChris Barker
Aug 30, 2019·Borderline Personality Disorder and Emotion Dysregulation·Sophie I LiljedahlSofie Westling

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04160871

Software Mentioned

Power

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.